Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Clinica ospedaliero-universitaria Policlinico Umberto I

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Clinica ospedaliero-universitaria Policlinico Umberto I is a historic and highly specialized public teaching hospital located at Viale del Policlinico, 155, 00161 Rome, Italy. Officially opened in 1903 after being championed by notable physicians and politicians like Guido Baccelli, it serves as the primary polyclinic for the Faculty of Medicine and Surgery of the Sapienza University of Rome. Spanning a massive geographic area of over 300,000 square meters with 54 internal buildings, it stands as the largest hospital in Europe by land area and the second-largest public hospital in Italy.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. University hospital

Business Subcategory

Source: Human-provided. University hospital
Source: Human-provided. General hospital
Source: Trial-derived.
101Total Trials
Source: Trial-derived.
27Recruiting Trials
Source: Trial-derived.
51Active Trials
Source: Trial-derived.
32Completed Trials
Source: Trial-derived.
135Unique Conditions
Source: Trial-derived.
90Unique Sponsors

Conditions

Source: Trial-derived. Pulmonary Arterial Hypertension (10)Source: Trial-derived. Breast Cancer (5)Source: Trial-derived. Ovarian Cancer (5)Source: Trial-derived. Cardiovascular Diseases (3)Source: Trial-derived. Myelofibrosis (3)Source: Trial-derived. Anemia (2)Source: Trial-derived. Atrial Fibrillation (2)Source: Trial-derived. Connective Tissue Diseases (2)

Sponsors

Source: Trial-derived. University of Roma La Sapienza (10)Source: Trial-derived. Mario Negri Institute for Pharmacological Research (6)Source: Trial-derived. Hoffmann-La Roche (5)Source: Trial-derived. Pfizer (5)Source: Trial-derived. Azienda Policlinico Umberto I (4)Source: Trial-derived. IRCCS Azienda Ospedaliero-Universitaria di Bologna (4)Source: Trial-derived. Eli Lilly and Company (3)Source: Trial-derived. Fondazione Policlinico Universitario Agostino Gemelli IRCCS (3)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture
Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. Six-minute walk test
Source: AI-inferred. MRI
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. CT Scan
Source: AI-inferred. Continuous glucose monitoring
Source: AI-inferred. PET-CT

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Histology / pathology
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Sequencing / genomics

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Cardiac catheterisation or electrophysiology procedures
Source: AI-inferred. Lumbar puncture
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Blood transfusion service
Source: AI-inferred. Peripheral angiography and endovascular intervention

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Electronic patient diary (eDiary)
Source: AI-inferred. Electronic patient-reported outcome (ePRO) system
Source: AI-inferred. Hand grip strength dynamometry (Martin Vigorimeter)
Source: AI-inferred. Hepatic fat fraction quantification
Source: AI-inferred. Intrathecal drug administration
Source: AI-inferred. Minimal residual disease (MRD) testing
Source: AI-inferred. Mixed-meal tolerance test (MMTT) with timed C-peptide sampling
Source: AI-inferred. Mixed-meal tolerance test with timed C-peptide sampling